Tag Archive for: Short

Arlo Technologies, Inc. (NYSE:ARLO) Short Interest Update

/in


Arlo Technologies, Inc. (NYSE:ARLO – Get Rating) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 1,890,000 shares, a decline of 30.3% from the November 15th total of 2,710,000 shares. Based on an average daily trading volume, of 671,600 shares, the days-to-cover ratio is currently 2.8 days.

Arlo Technologies Trading Down 3.9 %

ARLO stock traded down $0.13 during midday trading on Thursday, hitting $3.20. The stock had a trading volume of 648,152 shares, compared to its average volume of 771,459. The firm has a market cap of $283.11 million, a P/E ratio of -7.09 and a beta of 1.58. Arlo Technologies has a 1-year low of $2.93 and a 1-year high of $11.79. The business has a fifty day moving average price of $4.22 and a two-hundred day moving average price of $5.59.

Insiders Place Their Bets

In other Arlo Technologies news, Director Grady Summers purchased 30,000 shares of the business’s stock in a transaction dated Friday, November 11th. The shares were bought at an average price of $3.80 per share, for a total transaction of $114,000.00. Following the completion of the acquisition, the director now owns 219,729 shares in the company, valued at $834,970.20. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Arlo Technologies news, CEO Matthew Blake Mcrae purchased 20,400 shares of the business’s stock in a transaction dated Wednesday, November 9th. The shares were bought at an average price of $2.97 per share, for a total transaction of $60,588.00. Following the completion of the acquisition, the chief executive officer now owns 1,724,039 shares in the company, valued at $5,120,395.83. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Grady Summers purchased 30,000 shares of the business’s stock in a transaction dated Friday, November 11th. The shares were acquired at an average price of $3.80 per share, for a total transaction of $114,000.00. Following the acquisition, the director now owns…

Source…

Short Interest in Cyren Ltd. (NASDAQ:CYRN) Grows By 213.6%

/in


Cyren Ltd. (NASDAQ:CYRN – Get Rating) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 627,600 shares, a growth of 213.6% from the February 13th total of 200,100 shares. Based on an average daily trading volume, of 2,420,000 shares, the days-to-cover ratio is currently 0.3 days. Approximately 24.0% of the company’s stock are short sold.

Separately, StockNews.com started coverage on shares of Cyren in a research report on Thursday, March 3rd. They set a “sell” rating on the stock.

Several institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC increased its stake in shares of Cyren by 9.0% during the 2nd quarter. Renaissance Technologies LLC now owns 1,458,772 shares of the technology company’s stock worth $1,182,000 after purchasing an additional 120,000 shares during the last quarter. Goldman Sachs Group Inc. acquired a new position in shares of Cyren during the 2nd quarter worth about $79,000. Herald Investment Management Ltd increased its stake in shares of Cyren by 61.6% during the 3rd quarter. Herald Investment Management Ltd now owns 97,511 shares of the technology company’s stock worth $60,000 after purchasing an additional 37,160 shares during the last quarter. Squarepoint Ops LLC acquired a new position in shares of Cyren during the 2nd quarter worth about $51,000. Finally, Sassicaia Capital Advisers LLC acquired a new position in shares of Cyren during the 3rd quarter worth about $30,000. Institutional investors own 54.22% of the company’s stock.

(Ad)

No dictionary required, no complicated YouTube tutorials, no manuals written in code, just a guide for new options traders written in plain English.

Hi, I’m Justin Vaughn, seasoned options trader and author of the best e-book for beginners, “Options Basics”.

I’ll give you all the tools you need to start, plus a way around the pitfalls new traders fall into.

Cyren stock opened at $6.80 on Friday. The firm has a market capitalization of $30.82 million, a PE ratio of -1.21 and a beta of 0.17. The company’s 50-day moving average is $2.22 and its 200-day moving average is $1.09. Cyren has a…

Source…

Cyren Ltd. (NASDAQ:CYRN) Short Interest Down 28.7% in November

/in


Cyren Ltd. (NASDAQ:CYRN) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 1,640,000 shares, a drop of 28.7% from the November 15th total of 2,300,000 shares. Based on an average daily trading volume, of 4,940,000 shares, the short-interest ratio is currently 0.3 days. Currently, 3.7% of the shares of the company are sold short.

Shares of NASDAQ:CYRN traded up $0.01 on Friday, hitting $0.32. 742,921 shares of the company were exchanged, compared to its average volume of 2,382,500. The firm has a market capitalization of $29.10 million, a P/E ratio of -1.15 and a beta of 0.25. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.41. Cyren has a 1-year low of $0.29 and a 1-year high of $1.75. The stock’s 50 day moving average price is $0.44 and its 200 day moving average price is $0.56.

Cyren (NASDAQ:CYRN) last issued its quarterly earnings results on Monday, November 15th. The technology company reported ($0.06) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.06). The company had revenue of $7.46 million during the quarter. Cyren had a negative return on equity of 104.30% and a negative net margin of 63.77%.

A number of institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC grew its stake in Cyren by 9.0% during the 2nd quarter. Renaissance Technologies LLC now owns 1,458,772 shares of the technology company’s stock valued at $1,182,000 after purchasing an additional 120,000 shares during the last quarter. Goldman Sachs Group Inc. purchased a new stake in Cyren during the 2nd quarter valued at about $79,000. Herald Investment Management Ltd grew its stake in Cyren by 61.6% during the 3rd quarter. Herald Investment Management Ltd now owns 97,511 shares of the technology company’s stock valued at $60,000 after purchasing an additional 37,160 shares during the last quarter. Squarepoint Ops LLC purchased a new stake in Cyren during the 2nd quarter valued at about $51,000. Finally, Sassicaia Capital Advisers LLC purchased a new stake in Cyren during the 3rd quarter valued at about…

Source…

Short doc ‘Terror Contagion’ Investigates NSO And Its Pegasus Malware – Deadline

/in


With voting now underway for the Oscar documentary shortlists, Academy Doc Branch members are choosing from a variety of contenders, including one from Laura Poitras, director of the Oscar-winning Citizenfour.

Poitras’s earlier film focused on Edward Snowden, the whistleblower who revealed the existence of the National Security Agency’s secret and widespread surveillance programs. Her latest, the short documentary Terror Contagion, exposes the activities of a private Israeli company called NSO, maker of a spyware program that has been deployed by numerous governments to crack down on journalists, human rights advocates and others.

“It’s classified as a cyber weapon. This is how extremely violent and invasive this technology is,” Poitras tells Deadline. “NSO Group, this Israeli company, sells to other countries, often countries that have a very bad history or track record of human rights.”

A graphic from 'Terror Contagion'
A graphic from ‘Terror Contagion’ showing people and entities targeted by Pegasus software
Neon

Like Saudi Arabia. The regime allegedly used the Pegasus software to infect the phone of a Saudi dissident, Omar Abdulaziz, and through that hack was able to monitor one of his friends, the journalist Jamal Khashoggi, a columnist for the Washington Post. Khashoggi was subsequently assassinated in 2018; according to an assessment by the U.S. Director of National Intelligence, Saudi Arabia’s Crown Prince Muhammad bin Salman approved the murderous operation.

“This assassination was empowered with Israeli software,” Shourideh Malavi, a researcher with Forensic Architecture (FA), says in the film. FA describes itself as a “research agency, based at Goldsmiths, University of London, investigating human rights violations including violence committed by states, police forces, militaries, and corporations.” FA’s investigation of NSO Group and Pegasus forms the basis of Terror Contagion.

Abdulaziz was living in exile in Canada when he was hacked through Pegasus malware, evidence that governments can now track perceived opponents no matter their location.

“Pegasus is being used by governments… to track people even once they have left their…

Source…